Why Your Collagen May Not Have Changed Your Skin, and What the Clinical Research Actually Shows

If you’ve taken collagen for months without seeing a difference in your skin, one variable rarely gets discussed: peptide size. Hydrolyzed collagen is typically described in the literature as peptides of about 3,000–6,000 Daltons (León-López et al., 2019), and much of that is broken down during digestion into free amino acids and short fragments before it is ever absorbed, since the gut transports di- and tripeptides intact but there is little unequivocal evidence that larger peptides cross intact in physiologically relevant amounts (Miner-Williams et al., 2014). Small collagen tripeptides such as Gly-Pro-Hyp, at roughly 285 Daltons (PubChem CID 21252274), are absorbed intact more efficiently than larger peptides. Most published skin trials have used conventional multi-gram hydrolysates; a smaller number have tested tripeptide-standardized peptides at about 1,000 mg a day, and that is the specification this product discloses. Whether peptide size explains any individual’s experience with a previous product has not been tested head to head, so treat it as a formulation difference worth understanding, not a proven explanation.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

What Should You Look for in a Collagen Supplement for Skin, and Why Does Peptide Size Matter?

For women who have used collagen without seeing visible results, peptide size is a useful place to start. Standard hydrolyzed collagen is generally composed of peptides in the ~3,000–6,000 Dalton range, though this varies considerably by source and process (León-López et al., 2019). Much of that is broken down into free amino acids and short fragments before absorption.

Smaller collagen tripeptides, three-amino-acid fragments such as Gly-Pro-Hyp, molecular weight about 285 Daltons (PubChem CID 21252274), are more readily absorbed intact. Peer-reviewed pharmacokinetic research has detected small collagen peptides in human blood after oral collagen intake, with the peptide form of hydroxyproline peaking at 20–60 nmol/mL of plasma 1–2 hours after ingestion of 9.4–23 g of porcine- and chicken-derived gelatin hydrolysates, then falling to half that by 4 hours (Iwai et al., 2005). A later study using a high-tripeptide hydrolysate identified 17 collagen-derived peptides transiently in human plasma, with particular enrichment in Gly-Pro-Hyp (Yazaki et al., 2017). These absorption studies used higher amounts and different collagen sources than this product.

Tripeptide Pro™ Collagen Tripeptides is a low-molecular-weight fish collagen supplement standardized to a minimum 15% tripeptide content, 150 mg per serving, including Gly-Pro-Hyp among the standardized tripeptide fraction, delivered as 1,000 mg daily in 2 small capsules of 500 mg each. One published 12-week randomized, double-blind, placebo-controlled trial of a low-molecular-weight collagen peptide with a comparable tripeptide standard, at this same 1,000 mg daily amount, reported greater improvement than placebo in skin hydration (as early as 6 weeks) and, at 12 weeks, in the appearance of crow’s-feet wrinkles and two of three skin-elasticity measures in women aged 40–60, with no adverse reactions reported (Kim et al., 2018). A second trial at the same daily amount did not reproduce those visible-appearance results (Tak et al., 2021). Both trials used ingredients from other manufacturers and other fish species, in different delivery formats. The first was given as a liquid that contained 100 mg of vitamin C, but so did its placebo, so vitamin C was controlled for and does not explain the difference between groups; this product does not include vitamin C. This finished product has not itself been tested in a clinical trial, and the overall evidence for collagen and skin aging remains mixed.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

If You’ve Tried Collagen Before and Felt Let Down, Here’s the Part No One Explained

You did everything right. You picked a well-reviewed product, took it daily, and gave it the full 8–12 weeks the label suggested. Then you looked in the mirror, and nothing had really changed. After enough of that, it’s easy to start believing the skeptics who say collagen is a waste of money.

Maybe it was a powder, and the daily ritual- measuring, shaking, drinking past the texture, rinsing the bottle- became a small chore you skipped on busy or travel days. Maybe it was capsules, four a day, easy to forget. Either way, the frustration lands the same: you spent the money, kept the habit, and your hydration, fine lines, and firmness looked untouched.

Here’s a piece that often gets left out. Peptide size is a real formulation variable, and it is the one spec most labels rarely disclose. No published study has tested whether peptide size explains why a particular product didn’t work for a particular person, so we won’t tell you it was the reason. What we can say is that it is a difference you can actually verify on a label, and it is the difference a low-molecular-weight, tripeptide-standardized collagen is designed to address.

Why Do Peptide Size and Standardization Matter?

Whether it was a premium fish collagen powder, a multi-capsule collagen-plus-hyaluronic-acid formula, or a budget hydrolyzed collagen, most conventional collagen products share one thing the label rarely tells you: their peptide molecular weight.

Conventional collagen peptides

Standard hydrolyzed collagen is generally composed of peptides in the ~3,000–6,000 Dalton range, with wide source-dependent variation (León-López et al., 2019). A large share is broken down during digestion into shorter fragments and free amino acids- glycine, proline, hydroxyproline- which your body then draws on for whatever it needs, skin included, but not preferentially. That’s why conventional products are usually taken at multi-gram doses; doses in published skin trials range from about 0.4 g to 12 g per day, most commonly 2.5–10 g (Pu et al., 2023). It’s also a fair reason for the skepticism you’ll read online about collagen “just becoming expensive protein.”

“Low molecular weight” claims without numbers

Plenty of products advertise “low molecular weight for better absorption,” yet never state an actual Dalton figure. “Low” is relative. 2,000 Da is lower than 10,000 Da, but it’s still far above the size at which small di- and tripeptides are efficiently absorbed intact (Miner-Williams et al., 2014). Without a disclosed specification, “low MW” isn’t verifiable.

Missing tripeptide standardization

The fragments most studied for skin are small peptides like Pro-Hyp and Gly-Pro-Hyp. Many collagen products do not standardize or disclose a tripeptide percentage, so you can’t tell how much of the studied fraction you’re actually getting.

Format and consistency

Consistency over 8–12 weeks is what the clinical timelines require. Some people find a two-capsule routine easier to keep than measuring and mixing a powder; we have not measured adherence for this product, and the tripeptide trial that used four capsules a day still reported compliance above 88% (Tak et al., 2021). Treat format as a personal-preference factor, not a proven adherence advantage.

The variable most collagen labels leave out isn’t the brand. It’s disclosed low molecular weight plus standardized tripeptide content, delivered at an amount published trials have actually used.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

How Does Oral Collagen Actually Reach Your Skin?

Oral collagen reaches the bloodstream as small peptide fragments, not as whole collagen. Most collagen is digested into individual amino acids and short fragments, but very small collagen peptides, di- and tripeptides such as Pro-Hyp and Gly-Pro-Hyp, can be absorbed intact through the intestine’s PEPT1 peptide transporter (Miner-Williams et al., 2014). Peer-reviewed pharmacokinetic studies have detected these intact peptides in human blood after oral collagen intake (Iwai et al., 2005; Yazaki et al., 2017). Delivery of these peptides into skin tissue has been demonstrated in animal models; it has not yet been directly measured in human skin.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Here is the pathway in plain terms, with the evidence tier for each step stated so you can weigh it.

Step 1: Small Peptides Can Survive Digestion

When collagen is broken into very small fragments, di- and tripeptides, some can be absorbed intact instead of fully digested down to single amino acids. That’s established peptide physiology: the intestine has a dedicated transporter, PEPT1, that carries small di- and tripeptides across the gut wall, while there is little unequivocal evidence that peptides larger than tripeptides cross intact at meaningful concentrations (Miner-Williams et al., 2014).

Iwai and colleagues (2005) identified several intact food-derived collagen peptides in human blood after oral gelatin-hydrolysate intake, chiefly the dipeptide Pro-Hyp, alongside smaller amounts of tripeptides such as Pro-Hyp-Gly, with the peptide form of hydroxyproline peaking at 20–60 nmol/mL of plasma 1–2 hours after intake. Those volunteers took 9.4–23 g of porcine skin, chicken feet or chicken cartilage gelatin hydrolysate, which is a much larger amount and a different collagen source than this product provides.

Step 2: These Peptides Reach the Bloodstream, and, in Animal Studies, Skin

Later work by Yazaki and colleagues (2017) found that after oral intake of a high-tripeptide collagen hydrolysate, human plasma showed particular enrichment in the tripeptide Gly-Pro-Hyp, among 17 collagen-derived peptides detected transiently. In the same study’s mouse model, both Gly-Pro-Hyp and its hydrolyzed form Pro-Hyp were enriched in plasma and skin, with Pro-Hyp higher in skin.

In rats given collagen hydrolysate radiolabeled on either proline or the Gly-Pro-Hyp tripeptide, radioactivity remained at a high level in the skin until 14 days after administration, which traces where the labeled building blocks went rather than confirming intact peptide (Watanabe-Kamiyama et al., 2010). That study’s primary focus was bone, and the tripeptide itself accumulated in the kidney.

In other words: delivery of these peptides into skin tissue has been demonstrated in animals. Human skin-tissue delivery has not yet been directly measured.

Step 3: In Skin Cells, Collagen-Derived Peptides May Signal Fibroblasts

In laboratory studies on cultured human dermal fibroblasts, the collagen-derived dipeptide Pro-Hyp increased fibroblast proliferation 1.5-fold and hyaluronic acid synthesis 3.8-fold at a concentration of 200 nmol/mL (Ohara et al., 2010). That is a concentration applied directly to cells in a dish, not a blood level shown to result from a 1,000 mg oral serving. This is cell-culture evidence describing a possible mechanism; it has not been confirmed as the mechanism behind the clinical results in people. Fibroblasts are the cells that make collagen, elastin, and hyaluronic acid, the components tied to skin firmness and moisture.

Putting It Together

Tripeptide Pro™ Collagen Tripeptides supplies Gly-Pro-Hyp and other small peptides of the kind research has detected in human blood after oral collagen intake. Standardizing tripeptide content to a minimum of 15%, 150 mg per 1,000 mg serving, discloses how much of that studied fraction each serving contains, rather than leaving it incidental, and that is the reasoning behind a 1,000 mg daily amount rather than a multi-gram one. The steps above run from human blood-level data (strong) to animal skin-delivery data and cell-culture mechanism (supportive, not yet confirmed in human skin).

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

What Did the Clinical Research on Tripeptide Collagen Measure?

Individual results vary. The outcomes below are group averages from one published 12-week trial in 64 women aged 40–60 with dermatologist-assessed photoaged skin, measured by instrument and dermatologist grading. They are not guarantees of visible change for any individual, and a second trial at the same daily amount did not reproduce the visible-appearance findings.

Skin Hydration Support

What the research showed: In the published 12-week trial, skin hydration rose from 47.79 to 60.00 corneometer units in the collagen group versus 48.43 to 50.12 in placebo at 6 weeks (p < 0.001). The source expresses this as a 7.23-fold-larger increment, which reflects how little the placebo group moved rather than a sevenfold visible change.

By 12 weeks the collagen group’s increment was 2.9 times that of placebo (p = 0.003), and the between-group difference was significant at both 6 and 12 weeks.*

What the measure means in plain terms: Corneometer units track how much water the outermost layer of skin holds. Neither trial measured how skin subjectively felt, and the one trial that collected self-reported impressions found no difference from placebo.

The shift: From chasing dryness with topicals to supporting hydration from within.

Appearance of Fine Lines and Wrinkles

What the research showed: By 12 weeks, dermatologist-assessed crow’s-feet grade improved in the collagen group (3.23 to 2.81 on a 0–9 scale) while placebo was essentially unchanged (3.19 to 3.15); the between-group difference was statistically significant (p = 0.013). The source expresses this as an improvement increment about 10.5 times that of placebo, which again reflects how little placebo moved, not a tenfold change in anyone’s skin.

Three of five roughness parameters measured by Skin Visiometer (R1, R3, R4) improved significantly versus placebo (p = 0.043, 0.025, 0.004); R5 was borderline (p = 0.053) and R2 was not significant (p = 0.391).*

What the measure means in plain terms: Crow’s-feet grading is a dermatologist’s visual score; Visiometer roughness parameters are instrument readings taken from a skin replica. Both are group averages.

The shift: From managing the appearance of aging to supporting your skin’s structure.

Skin Elasticity Support

What the research showed: At 12 weeks, Cutometer elasticity parameters R2 (overall elasticity) and R5 (net elasticity) were significantly higher in the collagen group than placebo (p = 0.025 and p = 0.027).

R7 was not significant (p = 0.139).*

What the measure means in plain terms: Cutometer R2 and R5 track how far skin stretches under gentle suction and how fully it springs back. Note that the roughness and elasticity readings above come from two different instruments that happen to share R-number labels.

The shift: From feeling at the mercy of time to actively supporting firmness.

A Habit You Can Actually Keep

Why it matters: The measured changes emerged over 6–12 weeks of consistent daily intake. Some people find a two-capsule routine easier to keep than measuring and mixing a powder, though we have not measured adherence for this product. The published trials delivered this daily amount as a liquid that also contained 100 mg of vitamin C in both the active and placebo arms, or as four smaller capsules. The daily peptide amount is the same; the delivery format is not, and we make no claim that 2 capsules absorb better than 4.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

What Does the Full Body of Collagen Research Actually Say?

In a published 12-week randomized, double-blind, placebo-controlled study of 64 women aged 40–60 (53 completed), 1,000 mg daily of a low-molecular-weight collagen peptide with more than 15% tripeptides significantly improved skin hydration (as early as 6 weeks) and, at 12 weeks, the appearance of crow’s-feet wrinkles and two of three elasticity measures, with no adverse reactions reported. The trial was run at a single Korean research center (Ellead Skin and Bio Research), and the test material, a 50 mL liquid beverage, was supplied by the ingredient manufacturer, Newtree, which co-signs the paper’s conflict-of-interest declaration; the paper states the research received no external funding. Findings from one supplier-material trial at a single center should be read as promising, not definitive.*

The Most Relevant Trial, and How It Differs From This Product

Kim, D. U., Chung, H. C., Choi, J., Sakai, Y., & Lee, B. Y. (2018). Oral intake of low-molecular-weight collagen peptide improves hydration, elasticity, and wrinkling in human skin. Nutrients, 10(7), 826. PMID: 29949889.

·       Design: Randomized, double-blind, placebo-controlled; 64 women aged 40–60 with dermatologist-diagnosed crow’s-feet (global photodamage score 2–6); 70 recruited, 64 randomized, 53 completed. 1,000 mg/day of low-molecular-weight fish collagen peptide (>15% tripeptides, including 3% Gly-Pro-Hyp), delivered in a 50 mL liquid that also contained 100 mg vitamin C, for 12 weeks. Both the active and placebo beverages contained the same 100 mg of vitamin C, so vitamin C was controlled for and cannot explain the between-group differences.

·       Hydration: Significantly higher than placebo at 6 weeks (p < 0.001; the source prints 0.000) and 12 weeks (p = 0.003); increment 7.23 times greater than placebo at 6 weeks and 2.9 times greater at 12 weeks.

·       Wrinkles: Crow’s-feet visual grade significantly improved versus placebo at 12 weeks (increment about 10.5 times greater; p = 0.013); 3 of 5 Visiometer roughness parameters (R1, R3, R4) significantly improved versus placebo (p = 0.043, 0.025, 0.004), with R5 borderline (p = 0.053) and R2 not significant (p = 0.391).

·       Elasticity: Cutometer R2 and R5 significantly higher than placebo at 12 weeks (p = 0.025, 0.027); R7 not significant (p = 0.139).

·       Safety: No adverse reactions; blood, urine, and vital-sign parameters within normal ranges in both groups over 12 weeks in 53 completers, reassuring, but not a general safety guarantee.

·       Why it matters, and its limits: This study used the same 1,000 mg daily amount and a comparable tripeptide standard (>15% Gly-X-Y tripeptides, including 3% Gly-Pro-Hyp) as Tripeptide Pro™ Collagen Tripeptides. It differs from this product in three material ways. The peptide was a Type I hydrolysate from sutchi catfish (Pangasius hypophthalmus) skin supplied by Newtree of Seongnam, Korea, a different manufacturer and a different fish species from the ingredient used here. It was given as a 50 mL liquid rather than in capsules. And it did not test this finished product. On study quality: efficacy was analyzed per protocol among the 53 completers rather than by intention to treat, and the trial was conducted in 2012 but published in 2018. Read it as evidence about low-molecular-weight collagen peptides taken at this daily amount, not as a test of this product.

Absorption Evidence: How Small Peptides Get In

Iwai, K., et al. (2005). Journal of Agricultural and Food Chemistry, 53(16), 6531–6536. PMID: 16076145, Detected food-derived collagen peptides in human blood after ingestion of 9.4–23 g of porcine- and chicken-derived gelatin hydrolysate, chiefly Pro-Hyp, with peptide-hydroxyproline peaking at 20–60 nmol/mL 1–2 hours later.

Yazaki, M., et al. (2017). Journal of Agricultural and Food Chemistry, 65(11), 2315–2322. PMID: 28244315, Human plasma enriched in Gly-Pro-Hyp among 17 collagen-derived peptides detected transiently after oral collagen intake; plasma-and-skin enrichment shown in an in vivo mouse model.

Cellular Rationale (In Vitro)

Ohara, H., et al. (2010). The Journal of Dermatology, 37(4), 330–338. PMID: 20507402. The collagen-derived dipeptide Pro-Hyp stimulated fibroblast proliferation 1.5-fold and hyaluronic acid synthesis 3.8-fold at 200 nmol/mL in cultured human dermal fibroblasts (cell-culture study).

A Second Trial of Collagen Tripeptide, With Mixed Results

Tak, Y. J., et al. (2021). Frontiers in Medicine, 7, 608903 (NCT03505684), 84 women aged 40–60 were randomized (42 per arm); the per-protocol analysis reported here covers 36 collagen and 38 placebo participants, and the paper reports slightly differing analysis counts in different places (intention-to-treat 84 with imputation; 82 analyzed in the abstract). The intervention was 1,000 mg/day of collagen tripeptide (Nile tilapia skin, average MW 500 Da, 20% tripeptide including 3.2% Gly-Pro-Hyp, no vitamin C or other actives) for 12 weeks.

The trial’s primary endpoint, transepidermal water loss (a skin-barrier measure), separated from placebo only in covariate-adjusted models, adjusted for temperature and humidity (p = 0.024), for UVA (p = 0.032), and for temperature, high temperature and UVA (p = 0.031), while the unadjusted 12-week between-group difference was not significant (p = 0.168). On the visible-appearance secondary endpoints, this trial did not find a significant difference from placebo: skin hydration (p = 0.423 at 12 weeks), skin elasticity (p = 0.480), and dermatologist-graded crow’s-feet (p = 0.349 left, 0.514 right) all improved in both groups without separating. It was well tolerated, with reported compliance above 88%.

We include it because it cuts both ways: it’s the closest independent test of a 1,000 mg/day tripeptide dose in this age group, but its only positive finding was a covariate-adjusted barrier measure, and it did not replicate the visible wrinkle, elasticity, or hydration benefits seen in the primary trial. Note: 4 capsules/day, a different branded ingredient (Amicogen Collagen-Tripep20S), and three authors employed by Amicogen.

Category Evidence, and It’s Genuinely Mixed

Pu, S.-Y., et al. (2023). Nutrients, 15(9), 2080. PMID: 37432180, Across 26 RCTs and 1,721 participants, hydrolyzed collagen significantly improved skin hydration (18 studies; SMD 0.63, 95% CI 0.38–0.88; Z = 4.94, p < 0.00001) and elasticity (19 studies; SMD 0.72, 95% CI 0.40–1.03; Z = 4.49, p < 0.00001) versus placebo. Daily doses across the included trials ranged from about 0.4 g to 12 g. The authors noted several biases in the included trials and called for larger studies. Hydration effects varied by collagen source and duration, while for elasticity there was no significant difference between sources (p = 0.21).

A more skeptical analysis, Myung, S.-K., & Park, Y. (2025), The American Journal of Medicine, 138(9), 1264–1277, PMID: 40324552, pooled 23 RCTs (1,474 participants) and found improvements in hydration, elasticity, and wrinkles overall, but reported that significant effects appeared mainly in trials funded by pharmaceutical companies, and that when only high-quality trials were pooled, no significant effect remained. The authors concluded that “there is currently no clinical evidence to support the use of collagen supplements to prevent or treat skin aging.”

Those conclusions have been contested in a published Comment in the same journal (Rajan & Divyalakshmi, 2025), and collagen-industry groups have separately argued that several trials were misclassified by funding source (Collagen Stewardship Alliance statement; GROW statement). We’ll state the obvious: since we sell collagen, we are not a neutral party in that dispute. The honest position is that this is an area of active, contested research where individual results vary, not a settled one.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

How Do You Choose a Collagen Supplement Worth Taking?

Set against the collagen category, the differentiators come down to transparency and disclosed specifications: numbers you can verify, not adjectives. These are the criteria we formulated against; our product meets the disclosure and dosing criteria below, and our current Certificate of Analysis is available on the product page. Judge the reasoning, not the checkmarks.

For Disclosed Peptide Size

·       Best: A product that states its tripeptide percentage and the milligram amount that represents, as this one does: a minimum 15% tripeptide content, 150 mg per 1,000 mg serving.

·       Okay: “Low molecular weight” claims without a number.

·       Avoid: Generic hydrolyzed collagen with no molecular-weight or tripeptide disclosure.

For Evidence at the Amount You’ll Actually Take

·       Best: A disclosed tripeptide standard at a daily amount that published trials have actually used (1,000 mg/day, ≥15% tripeptides), with the differences from those trials stated plainly.

·       Okay: Products citing studies run at different doses or on different formulations.

·       Avoid: “Clinically proven” with no accessible citation.

For Daily Consistency

·       Best: A routine you will actually keep; for many people, that is two capsules a day.

·       Okay: 3–4 capsules daily.

·       Avoid: Large-dose powders if mixing friction makes you skip days.

For Verifiable Quality

·       Best: Testing you can confirm with a certificate or lot-linked Certificate of Analysis.

·       Okay: Certifications named but not documented.

·       Avoid: Self-described “sustainable” or “pure” with no verification.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Frequently Asked Questions About Tripeptide Collagen

How is tripeptide collagen different from regular collagen?

It comes down to peptide size. Conventional collagen peptides are larger, generally ~3,000–6,000 Daltons (León-López et al., 2019), and much of the dose is broken down into shorter fragments and free amino acids before absorption. Collagen tripeptides are much smaller, around 285 Daltons for Gly-Pro-Hyp, and peer-reviewed research has detected small collagen peptides in human blood after oral intake (Iwai et al., 2005). Tripeptide Pro™ Collagen Tripeptides is standardized to a minimum 15% tripeptide content, so the share of small peptides in each serving is disclosed rather than incidental. That is why the daily amount is 1,000 mg, the amount used in published trials of low-molecular-weight collagen peptides, rather than a multi-gram serving.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

How long until I might see a difference?

In the published 12-week trial, skin-hydration improvements appeared as early as 6 weeks, and wrinkle-appearance and elasticity improvements were significant at 12 weeks. A second trial at the same daily amount did not reproduce those visible-appearance results. Those were group averages, and individual results vary. Give it a consistent 8–12 weeks.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Is it safe, and are there interactions?

In the published 12-week trial of a comparable low-molecular-weight collagen peptide, a different manufacturer’s ingredient from a different fish species, given as a liquid, no adverse reactions were reported among 53 completers, and blood-chemistry, urine, and vital-sign values stayed within normal ranges in both groups. That is reassuring about the ingredient class, not a safety dataset for this finished product, which has not been clinically tested. Because it’s a fish-derived collagen, don’t take it if you have a fish allergy. If you’re pregnant or nursing, or you take prescription medications, talk with your healthcare provider before starting any new supplement.

Why is the daily amount only 1,000 mg when other collagens use several grams?

Because standardizing for small, absorbable tripeptides changes the math. The published clinical results for low-molecular-weight, tripeptide-standardized collagen peptides appeared at 1,000 mg/day, whereas conventional powders are usually dosed at multi-gram servings, doses in published skin trials range from about 0.4 g to 12 g per day, most commonly 2.5–10 g (Pu et al., 2023).

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Does it matter that it’s fish rather than bovine collagen?

Type I collagen is the most common collagen type in skin (León-López et al., 2019), and fish skin and scales are established sources of Type I collagen hydrolysates; the primary trial’s material was a Type I hydrolysate from catfish skin (Kim et al., 2018). That said, a meta-analysis found no significant difference between collagen sources for elasticity, though hydration effects did vary by source (Pu et al., 2023), so source is one factor among several. Peptide size, tripeptide content, dose, and consistency all matter too.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Can I take it with my other supplements or skincare?

No interaction studies have been conducted on this product. Collagen peptides are a dietary protein and are not known to interact with common supplements or topical skincare, but if you take prescription medications or have a medical condition, check with your healthcare provider before adding anything new. Keep up your usual skincare, this supports skin from within and isn’t a replacement for sun protection.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Is it suitable during pregnancy or breastfeeding?

This hasn’t been specifically studied in that setting, so defer to your healthcare provider.

What if I have a fish allergy?

Don’t take it. It’s a fish-derived product and can trigger an allergic reaction. Fish is one of the nine major food allergens identified by the FDA (FDA — Food Allergies).

Is it suitable for vegans or vegetarians?

No. Collagen is an animal-derived protein, and this is a fish-derived collagen peptide. The capsule shell itself is vegetarian HPMC, but the collagen inside it is not.

What’s in each capsule, and how should I store it?

Each capsule contains 500 mg of fish collagen tripeptides, and a serving is 2 capsules, 1,000 mg daily. A bottle holds 60 capsules, or 30 servings. The ingredient is standardized to a minimum 15% tripeptide content (150 mg per serving) and a minimum 8% hydroxyproline (80 mg per serving), with total protein not less than 90%. The capsule shell is vegetarian HPMC, though the collagen itself is fish-derived, so the product is not vegetarian or vegan. Shelf life is 24 months from the manufacture date. Store it in a cool, dry place below 25 °C.

What results are realistic?

In the research, support for hydration, elasticity, and the appearance of fine lines emerged over 8–12 weeks of consistent use, as group averages, and one trial at the same daily amount did not reproduce the visible-appearance findings. It supports your skin’s natural processes; it doesn’t “reverse” aging or replace medical or dermatological treatment. Individual results vary, and the broader evidence base is mixed.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Support Your Skin’s Hydration, Firmness, and Smoothness from the Inside

Tripeptide Pro™ Collagen Tripeptides is a low-molecular-weight fish collagen supplement standardized to a minimum 15% tripeptide content, 150 mg per serving, including Gly-Pro-Hyp among the standardized tripeptide fraction, taken as 1,000 mg daily in two capsules. That is the same daily amount used in published randomized, double-blind, placebo-controlled trials of low-molecular-weight collagen peptides; one of those trials reported improvements in skin hydration, elasticity, and wrinkle appearance in women aged 40–60, and a second did not reproduce those visible-appearance results. Those trials used other manufacturers’ ingredients in other formats, and this finished product has not itself been tested in a clinical trial.

The difference here isn’t a bigger promise. It’s a disclosed specification: a minimum 15% tripeptide content, 150 mg per serving, in two capsules a day.

It’s also fair to say the overall evidence for collagen and skin aging is still mixed and actively debated. A low-molecular-weight tripeptide collagen like this one tends to suit people who want to support their skin from within and prefer a disclosed specification over unquantified claims; who haven’t found results with conventional collagen; who value a simple daily routine; and who want a standardized, disclosed tripeptide content instead of an unquantified “low molecular weight” claim. It may not fit when budget is the only priority; when joint support is the main goal, since skin is the studied use here; when a vegan or vegetarian diet rules out animal-derived collagen; or when a fish allergy is present, which is an absolute reason to avoid it.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Scientific References and Citations

Collagen Stewardship Alliance. (2025). CSA statement on 2025 collagen meta-analysis [Industry statement]. https://collagenalliance.org/csa-statement-on-2025-collagen-meta-analysis/

Gelatin Manufacturers of the World. (2025). GROW defends scientific integrity in response to Myung et al. (2025) [Industry statement]. https://www.gelatininfo.com/fileadmin/user_upload/grow_content/Statements_and_Publications/GROW_Statement_CP-Analysis_Final.pdf

Iwai, K., Hasegawa, T., Taguchi, Y., Morimatsu, F., Sato, K., Nakamura, Y., Higashi, A., Kido, Y., Nakabo, Y., & Ohtsuki, K. (2005). Identification of food-derived collagen peptides in human blood after oral ingestion of gelatin hydrolysates. Journal of Agricultural and Food Chemistry, 53(16), 6531–6536. https://doi.org/10.1021/jf050206p

Kim, D. U., Chung, H. C., Choi, J., Sakai, Y., & Lee, B. Y. (2018). Oral intake of low-molecular-weight collagen peptide improves hydration, elasticity, and wrinkling in human skin: A randomized, double-blind, placebo-controlled study. Nutrients, 10(7), 826. https://doi.org/10.3390/nu10070826

León-López, A., Morales-Peñaloza, A., Martínez-Juárez, V. M., Vargas-Torres, A., Zeugolis, D. I., & Aguirre-Álvarez, G. (2019). Hydrolyzed collagen—Sources and applications. Molecules, 24(22), 4031. https://doi.org/10.3390/molecules24224031

Miner-Williams, W. M., Stevens, B. R., & Moughan, P. J. (2014). Are intact peptides absorbed from the healthy gut in the adult human? Nutrition Research Reviews, 27(2), 308–329. https://doi.org/10.1017/S0954422414000225

Myung, S.-K., & Park, Y. (2025). Effects of collagen supplements on skin aging: A systematic review and meta-analysis of randomized controlled trials. The American Journal of Medicine, 138(9), 1264–1277. https://doi.org/10.1016/j.amjmed.2025.04.034

National Center for Biotechnology Information. (n.d.). PubChem compound summary for CID 21252274, Gly-Pro-Hyp. U.S. National Library of Medicine. https://pubchem.ncbi.nlm.nih.gov/compound/21252274

Ohara, H., Ichikawa, S., Matsumoto, H., Akiyama, M., Fujimoto, N., Kobayashi, T., & Tajima, S. (2010). Collagen-derived dipeptide, proline-hydroxyproline, stimulates cell proliferation and hyaluronic acid synthesis in cultured human dermal fibroblasts. The Journal of Dermatology, 37(4), 330–338. https://doi.org/10.1111/j.1346-8138.2010.00827.x

Pu, S.-Y., Huang, Y.-L., Pu, C.-M., Kang, Y.-N., Hoang, K. D., Chen, K.-H., & Chen, C. (2023). Effects of oral collagen for skin anti-aging: A systematic review and meta-analysis. Nutrients, 15(9), 2080. https://doi.org/10.3390/nu15092080

Rajan, R., & Divyalakshmi, C. (2025). Comments on effects of collagen supplements on skin aging. The American Journal of Medicine, 138(11), e249. https://doi.org/10.1016/j.amjmed.2025.07.018

Tak, Y. J., Shin, D. K., Kim, A. H., Kim, J. I., Lee, Y. L., Ko, H.-C., Kim, Y.-W., & Lee, S. Y. (2021). Effect of collagen tripeptide and adjusting for climate change on skin hydration in middle-aged women: A randomized, double-blind, placebo-controlled trial. Frontiers in Medicine, 7, 608903. https://doi.org/10.3389/fmed.2020.608903

U.S. Food and Drug Administration. (2024). Food allergies. https://www.fda.gov/food/food-labeling-nutrition/food-allergies

Watanabe-Kamiyama, M., Shimizu, M., Kamiyama, S., Taguchi, Y., Sone, H., Morimatsu, F., Shirakawa, H., Furukawa, Y., & Komai, M. (2010). Absorption and effectiveness of orally administered low molecular weight collagen hydrolysate in rats. Journal of Agricultural and Food Chemistry, 58(2), 835–841. https://doi.org/10.1021/jf9031487

Yazaki, M., Ito, Y., Yamada, M., Goulas, S., Teramoto, S., Nakaya, M.-A., Ohno, S., & Yamaguchi, K. (2017). Oral ingestion of collagen hydrolysate leads to the transportation of highly concentrated Gly-Pro-Hyp and its hydrolyzed form of Pro-Hyp into the bloodstream and skin. Journal of Agricultural and Food Chemistry, 65(11), 2315–2322. https://doi.org/10.1021/acs.jafc.6b05679